Zobrazeno 1 - 10
of 24
pro vyhledávání: '"G J, Parry"'
Autor:
R C, Parslow, R C, Tasker, E S, Draper, G J, Parry, S, Jones, T, Chater, K, Thiru, P A, McKinney, Debbie, White
Publikováno v:
Archives of Disease in Childhood. 94:210-215
The purpose of this work was to investigate the incidence rate for admission and mortality of children receiving paediatric intensive care in relation to socioeconomic status and ethnicity in England and Wales.National cohort of sequential hospital a
Publikováno v:
BMJ (Clinical research ed.). 316(7149)
To assess whether crude league tables of mortality and league tables of risk adjusted mortality accurately reflect the performance of hospitals.Longitudinal study of mortality occurring in hospital.9 neonatal intensive care units in the United Kingdo
Autor:
A S, Pakiam, G J, Parry
Publikováno v:
Musclenerve. 21(2)
One of the defining electrophysiological characteristics of multifocal motor neuropathy (MMN) is focal motor nerve conduction block. We have noted occasional patients with typical clinical features of MMN in whom there is no demonstrable conduction b
Autor:
D, McGuire, L, Garrison, C, Armon, R J, Barohn, W W, Bryan, R, Miller, G J, Parry, J H, Petajan, M A, Ross
Publikováno v:
Journal of the neurological sciences. 152
We previously demonstrated a significant relationship (P0.0001) between maximum voluntary isometric contraction (MVC) plus pulmonary function scores (the Tufts Quantitative Neuromuscular Exam Combination Megascore (TQNE CM)), and the Sickness Impact
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
R J, Hoagland, M, Mendoza, C, Armon, R J, Barohn, W W, Bryan, J C, Goodpasture, R G, Miller, G J, Parry, J H, Petajan, M A, Ross
Publikováno v:
Musclenerve. 20(6)
Maximal voluntary isometric contraction (MVIC) is becoming widely used for monitoring disease progression in amyotrophic lateral sclerosis (ALS). We evaluated the variability of MVIC in a large multicenter (29 sites) drug trial in ALS. Intra- and int
Autor:
R G, Miller, D, Moore, L A, Young, C, Armon, R J, Barohn, M B, Bromberg, W W, Bryan, D F, Gelinas, M C, Mendoza, H E, Neville, G J, Parry, J H, Petajan, J M, Ravits, S P, Ringel, M A, Ross
Publikováno v:
Neurology. 47(6)
We designed a phase II trial to evaluate the efficacy of gabapentin in slowing the rate of decline in muscle strength of patients with amyotrophic lateral sclerosis (ALS) and to assess safety and tolerability. Gabapentin (800 mg) or placebo was admin
Autor:
G J, Parry
Publikováno v:
Musclenerve. 19(3)
A 73-year-old man with a 16-year history of fasciculations and 15 years of weakness in his right arm was diagnosed with focal motor neuron disease. After 10 years of purely motor symptoms, he developed mild parasthesias although his sensory examinati
Autor:
R G, Miller, J H, Petajan, W W, Bryan, C, Armon, R J, Barohn, J C, Goodpasture, R J, Hoagland, G J, Parry, M A, Ross, S C, Stromatt
Publikováno v:
Annals of neurology. 39(2)
Preclinical investigations indicated that recombinant human ciliary neurotrophic factor (rhCNTF) may have potential as therapy for amyotrophic lateral sclerosis (ALS). We evaluated the safety and efficacy of rhCNTF in a prospective, double-blind, pla
Publikováno v:
Proceedings of the XV Symposium Neuroradiologicum ISBN: 9783642794360
The extent of HTLV-1 myelopathy and encephalopathy can be shown by standard MRI techniques without intravenous contrast medium injections. CT myelography is less sensitive but can show advanced myelopathy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22777de79c071a4da871ec75936b3821
https://doi.org/10.1007/978-3-642-79434-6_102
https://doi.org/10.1007/978-3-642-79434-6_102